United States Antineoplastic Agents Market Report to 2021

November 2016 | 105 pages | ID: U368D94A646EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antineoplastic Agents

Revenue, means the sales value of Antineoplastic Agents

This report studies sales (consumption) of Antineoplastic Agents in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Pfizer, Inc.
• Roche
• Sanofi
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• AstraZeneca plc.
• Eli Lilly and Company
• Abbvie
• AMGen
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Bristol-Myers Squibb
• Astellas Pharma
• Daiichi Sankyo

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Alkylating Agent
• Anti-metabolic Tumor Drugs
• Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives
• Others

Split by applications, this report focuses on sales, market share and growth rate of Antineoplastic Agents in each application, can be divided into

• First Level Hospital
• Two Level Hospital
• Three Level Hospital
• Others

Contents

United States Antineoplastic Agents Market Report 2021

1 ANTINEOPLASTIC AGENTS OVERVIEW

1.1 Product Overview and Scope of Antineoplastic Agents
1.2 Classification of Antineoplastic Agents
  1.2.1 Alkylating Agent
  1.2.2 Anti-metabolic Tumor Drugs
  1.2.3 Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives
  1.2.4 Others
1.3 Applications of Antineoplastic Agents
  1.3.1 First Level Hospital
  1.3.2 Two Level Hospital
  1.3.3 Three Level Hospital
  1.3.4 Others
1.4 USA Market Size (Value and Volume) of Antineoplastic Agents (2011-2021)
  1.4.1 USA Antineoplastic Agents Sales, Revenue and Price (2011-2021)
  1.4.2 USA Antineoplastic Agents Sales and Growth Rate (2011-2021)
  1.4.3 USA Antineoplastic Agents Revenue and Growth Rate (2011-2021)

2 USA ANTINEOPLASTIC AGENTS COMPETITION BY MANUFACTURERS

2.1 USA Antineoplastic Agents Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Antineoplastic Agents Revenue and Share by Manufactures (2015 and 2016)

3 USA ANTINEOPLASTIC AGENTS (VOLUME AND VALUE) BY TYPE

3.1 USA Antineoplastic Agents Sales and Market Share by Type (2011-2021)
3.2 USA Antineoplastic Agents Revenue and Market Share by Type (2011-2021)

4 USA ANTINEOPLASTIC AGENTS (VOLUME) BY APPLICATION

5 USA ANTINEOPLASTIC AGENTS MANUFACTURERS ANALYSIS

5.1 Novartis
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Antineoplastic Agents Product Type and Technology
    5.1.2.1 Alkylating Agent
    5.1.2.2 Anti-metabolic Tumor Drugs
  5.1.3 Antineoplastic Agents Sales, Revenue, Price of Novartis (2015 and 2016)
5.2 Pfizer, Inc.
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Alkylating Agent
    5.2.2.2 Anti-metabolic Tumor Drugs
  5.2.3 Pharmaceuticals Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
5.3 Roche
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Roche Product Type and Technology
    5.3.2.1 Alkylating Agent
    5.3.2.2 Anti-metabolic Tumor Drugs
  5.3.3 Roche Sales, Revenue, Price of Roche (2015 and 2016)
5.4 Sanofi
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Eli Lilly and Company Product Type and Technology
    5.4.2.1 Alkylating Agent
    5.4.2.2 Anti-metabolic Tumor Drugs
  5.4.3 Sanofi Sales, Revenue, Price of Sanofi (2015 and 2016)
5.5 Merck & Co., Inc.
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Merck & Co., Inc. Product Type and Technology
    5.5.2.1 Alkylating Agent
    5.5.2.2 Anti-metabolic Tumor Drugs
  5.5.3 Merck & Co., Inc. Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
5.6 GlaxoSmithKline plc
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 GlaxoSmithKline plc Product Type and Technology
    5.6.2.1 Alkylating Agent
    5.6.2.2 Anti-metabolic Tumor Drugs
  5.6.3 GlaxoSmithKline plc Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
5.7 Johnson & Johnson
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 Johnson & Johnson Product Type and Technology
    5.7.2.1 Alkylating Agent
    5.7.2.2 Anti-metabolic Tumor Drugs
  5.7.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
5.8 AstraZeneca plc.
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 AstraZeneca plc. Product Type and Technology
    5.8.2.1 Alkylating Agent
    5.8.2.2 Anti-metabolic Tumor Drugs
  5.8.3 AstraZeneca plc. Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
5.9 Eli Lilly and Company
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 Eli Lilly and Company Product Type and Technology
    5.9.2.1 Alkylating Agent
    5.9.2.2 Anti-metabolic Tumor Drugs
  5.9.3 Eli Lilly and Company Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
5.10 Abbvie
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Abbvie Product Type and Technology
    5.10.2.1 Alkylating Agent
    5.10.2.2 Anti-metabolic Tumor Drugs
  5.10.3 Abbvie Sales, Revenue, Price of Abbvie (2015 and 2016)
5.11 AMGen
5.12 Teva Pharmaceutical Industries Ltd.
5.13 Bayer AG
5.14 Bristol-Myers Squibb
5.15 Astellas Pharma
5.16 Daiichi Sankyo

6 ANTINEOPLASTIC AGENTS TECHNOLOGY AND DEVELOPMENT TREND

6.1 Antineoplastic Agents Technology Analysis
6.2 Antineoplastic Agents Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antineoplastic Agents
Table Classification of Antineoplastic Agents
Figure USA Sales Market Share of Antineoplastic Agents by Type in 2015
Figure Alkylating Agent Picture
Figure Anti-metabolic Tumor Drugs Picture
Figure Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives Picture
Figure Others Picture
Table Applications of Antineoplastic Agents
Figure USA Sales Market Share of Antineoplastic Agents by Application in 2015
Figure First Level Hospital Examples
Figure Two Level Hospital Examples
Figure Three Level Hospital Examples
Figure Others Examples
Table USA Antineoplastic Agents Sales, Revenue and Price (2011-2021)
Figure USA Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure USA Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Table USA Antineoplastic Agents Sales of Key Manufacturers (2015 and 2016)
Table USA Antineoplastic Agents Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antineoplastic Agents Sales Share by Manufacturers
Figure 2016 Antineoplastic Agents Sales Share by Manufacturers
Table USA Antineoplastic Agents Revenue by Manufacturers (2015 and 2016)
Table USA Antineoplastic Agents Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Antineoplastic Agents Revenue Share by Manufacturers
Table 2016 USA Antineoplastic Agents Revenue Share by Manufacturers
Table USA Antineoplastic Agents Sales and Market Share by Type (2011-2021)
Table USA Antineoplastic Agents Sales Share by Type (2011-2021)
Figure Sales Market Share of Antineoplastic Agents by Type (2011-2021)
Figure USA Antineoplastic Agents Sales Growth Rate by Type (2011-2021)
Table USA Antineoplastic Agents Revenue and Market Share by Type (2011-2021)
Table USA Antineoplastic Agents Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Antineoplastic Agents by Type (2011-2021)
Figure USA Antineoplastic Agents Revenue Growth Rate by Type (2011-2021)
Table USA Antineoplastic Agents Sales and Market Share by Application (2011-2021)
Table USA Antineoplastic Agents Sales Share by Application (2011-2021)
Figure Sales Market Share of Antineoplastic Agents by Application (2011-2021)
Figure USA Antineoplastic Agents Sales Growth Rate by Application (2011-2021)
Table Novartis Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Abbvie (2015 and 2016)
Table AMGen Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of AMGen (2015 and 2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
Table Bayer AG Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Bayer AG (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table Daiichi Sankyo Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)